ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Emmprin"

  • Abstract Number: 1246 • ACR Convergence 2021

    The Effect of Tocilizumab on miR-146a-5p and EMMPRIN/CD147 in Rheumatoid Arthritis Patients

    Devy Zisman1, Mirna Safieh1, Elina Simanovich1, Joy Feld2, Amalia Kinarty1, Liron Zisman1, Tal Gazitt3, Amir Haddad4, Muna Elias1, Itzhak Rosner5, Lisa Kaly6 and Michal A Rahat7, 1Carmel Medical Center, Haifa, Israel, 2Carmel and Zvulun Medical Centre, Haifa, Israel, 3Carmel Hospital, Haifa, Israel, 4Carmel Medical Centre, Haifa, Israel, 5Rheumatology Unit, Bnai Zion Medical Center, Haifa, Israel, 6Bnei Zion Medical Center, Haifa, Israel, 7Carmel Medical Center/Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

    Background/Purpose: Angiogenesis is an important contributor to the development of rheumatoid arthritis (RA). Tocilizumab (TCZ), an anti-IL-6 receptor antibody used in the treatment of RA…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences